You searched for "Cocaine"
Lenire tinnitus treatment device now available in Canada
The Lenire® tinnitus treatment device is now available in Canada through 21 clinics across Alberta, British Colombia, Manitoba, Ontarioand Québec. Forty-three percent of Canadians (11.2 million) report experiencing tinnitus in their lifetime, with 37% (9.2 million) experiencing tinnitus in the...EVOTION: Big data supporting public health policies for hearing loss
Big Data? Biosensors, smart hearing aids and smartphones? The EVOTION Project has it all and more! What will this project tell us about the future of hearing management? Doris-Eva Bamiou, Giorgos Dritsakis and Louisa Murdin, members of the EVOTION team,...Young CEORL-HNS: empowering the future of otorhinolaryngology
Young CEORL-HNS is a subgroup within CEORL-HNS which encompasses new specialists in ENT within training and up to the first decade or so as an accredited specialist. Giuditta Mannelli is the current president and is a head and neck surgeon...IFOS 2026 bid cities
As Dubai prepares to host IFOS 2023, the next IFOS congress in 2026 is already being planned. The competition to host the meeting is certain to be fierce – we hear from the organisers around the world bidding to bring...
AM and the neck
Infections with atypical mycobacteria (AM) are increasing, especially with the decline in BCG immunisation. The most frequent presentation is a lymphadenopathy in an immunocompetent child. This poses a difficult diagnostic challenge if the clinician is not aware of this entity....
Clival chordoma recurrence
Chordomas are generally slow growing and are histologically considered low grade tumours. Their high recurrence rate even after postoperative radiation renders them difficult to treat. This is particularly true for clival chordomas whose deep anatomic location and proximity to vital...
Cognition outcomes after cochlear implantation – is there an improvement?
Older adults with a severe to profound hearing loss are more at risk of cognitive decline than adults of a similar age with milder losses or normal hearing. This poses challenges, not only in the assessment process, but also for...
Everyone has the right to say no
Despite the introduction of the Mental Capacity Act in 2005, healthcare professionals remain uncomfortable with individuals who choose not to follow medical advice - who make informed decisions to decline a treatment or management plans. This paper highlights that speech...
Speedy speedy: people with MND chew faster but speak slower
Motor Neurone Disease (MND) is a progressive neurological condition that affects motor neurons in the brain, brainstem and spinal cord, affecting the control of skeletal muscles for speech, chewing and swallowing. There are two variants of MND, with symptoms typically...
The right to choose: stories from the rare dementias
People with primary progressive aphasia (PPA) experience an insidious onset and gradual decline in language on a background of lesser or no cognitive impairment, hence a language-led dementia. There are three different PPA variants that correspond with three different clinical...
The hidden dementia in motor neurone disease
It is now well recognised that people with motor neurone disease (also known as amyotrophic lateral sclerosis) are at risk of developing frontotemporal dementia. It can be difficult to recognise the symptoms of cognitive decline in this group due to...
